[Skip navigation] FDA Logo links to FDA home page
Center for Drug Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Drug Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER

horizonal rule
CDER Home About CDER Drug Information Regulatory Guidance CDER Calendar Specific Audiences CDER Archives
 
Powered by Google
 

Rulemaking History for OTC Colloidal Silver Drug Products
View by Date

Final Monographs (21 CFR 310.548):
Drug products containing colloidal silver ingredients or silver salts offered over-the-counter (OTC) for the treatment and/or prevention of disease

Note: This page links to PDF files which require the free Adobe Acrobat Reader.


Colloidal Silver Drug Products
Proposed Rule Date FR Citation
Proposed Rule 10/15/1996 61FR53685
Final Rule Date FR Citation
Final Rule: Classifies silver salts (internal or external use) as nonmonograph 8/17/1999 64FR44653

top arrow Back to Top     back arrow Back to Rulemaking Index

Date created: December 28, 2006; Last updated: May 4, 2007
horizonal rule

CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

FDA/Center for Drug Evaluation and Research